Rx Industry Must Take Phase IV “Seriously,” Commissioner Tells PhRMA

Pharmaceutical manufacturers need to step up their commitment to postmarketing surveillance and studies, FDA Commissioner McClellan told the Pharmaceutical Research & Manufacturers of America March 28 in Naples, Fla